New Key Statistics Module, Z-Score and F-Score
OTCPK:NONOF Key Ratios
| Market Cap $ M | 203,488.44 |
| Enterprise Value $ M | 213,309.84 |
| P/E(ttm) | 11.06 |
| PE Ratio without NRI | 12.39 |
| Forward PE Ratio | 13.21 |
| Price/Book | 5.76 |
| Price/Sales | 3.90 |
| Price/Free Cash Flow | 26.73 |
| Price/Owner Earnings | 9.82 |
| Payout Ratio % | 0.50 |
| Revenue (TTM) $ M | 51,267.00 |
| EPS (TTM) $ | 4.07 |
| Beneish M-Score | -2.39 |
| 10-y EBITDA Growth Rate % | 15.00 |
| 5-y EBITDA Growth Rate % | 25.90 |
| y-y EBITDA Growth Rate % | -3.70 |
| EV-to-EBIT | 9.18 |
| EV-to-EBITDA | 8.25 |
| PEG | 0.48 |
| Shares Outstanding M | 4,421.03 |
| Net Margin (%) | 35.35 |
| Operating Margin % | 43.13 |
| Pre-tax Margin (%) | 45.15 |
| Quick Ratio | 0.66 |
| Current Ratio | 0.87 |
| ROA % (ttm) | 21.63 |
| ROE % (ttm) | 60.88 |
| ROIC % (ttm) | 23.85 |
| Dividend Yield % | 3.99 |
| Altman Z-Score | 3.94 |
NONOF Number of Guru Trades
NONOF Volume of Guru Trades
Gurus Latest Trades with OTCPK:NONOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:NONOF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Novo Nordisk AS Insider Transactions
No Available Data
News about OTCPK:NONOF
Total 0- 1